News

Unpacking D-Wave Quantum's Options Movements for Investors

Unpacking D-Wave Quantum's Options Movements for Investors

Understanding D-Wave Quantum's Options Dynamics

Financial giants have made a notable bearish move regarding D-Wave Quantum. Our analysis of options history for D-Wave Quantum (NYSE: QBTS) has revealed some unusual trading activity.

Options Analysis Overview

Diving deeper into the specifics, we found that out of all traders, 37% exhibited bullish sentiments, while 50% leaned towards bearish tendencies. Among the trades observed, 3 were puts worth a total of $255,330, alongside 5 calls that amounted to $913,011.

Projected Price Targets

Considering the recent trading patterns, it appears that significant investors are targeting a price range from $23.00 to $45.00 for D-Wave Quantum over the past three months. This range could potentially guide investor strategies moving forward.

Volume and Open Interest Trends

In the current trading landscape, the average open interest in options for D-Wave Quantum is approximately 1918.75, with total volume hitting 4,226.00. The accompanying details illustrate the evolution of call and put option volume as well as open interest for significant trades within the strike price corridor of $23.00 to $45.00 over the last 30 days.

An Overview of Call and Put Volume

In the past month, the activity related to call and put options has shown varied sentiments. Traders actively monitored movements and strategized based on market conditions.

Noteworthy Options Activity

Several significant trades captured our attention:

  • Symbol: QBTS, Trade Type: CALL SWEEP, Sentiment: BEARISH, Expiration Date: 04/17/26, Price: $6.05
  • Symbol: QBTS, Trade Type: CALL TRADE, Sentiment: BULLISH, Expiration Date: 03/20/26, Price: $4.80
  • Symbol: QBTS, Trade Type: PUT SWEEP, Sentiment: BULLISH, Expiration Date: 04/17/26, Price: $8.35
  • Symbol: QBTS, Trade Type: CALL SWEEP, Sentiment: BEARISH, Expiration Date: 01/16/26, Price: $0.81
  • Symbol: QBTS, Trade Type: CALL SWEEP, Sentiment: BEARISH, Expiration Date: 04/17/26, Price: $3.95

About D-Wave Quantum

D-Wave Quantum Inc specializes in creating and delivering quantum computing systems, software, and services. As the only supplier of both annealing quantum computers and gate-model quantum computers, D-Wave leverages practical quantum applications for a variety of challenges in sectors like logistics, artificial intelligence, materials science, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Their annealing quantum computers can be accessed via LeapTM cloud services.

Current Market Status of D-Wave Quantum

  • Currently, D-Wave Quantum holds a trading volume of 4,769,229, with the stock price down by -3.47%, standing at $28.11.
  • The current RSI values suggest that the stock may be nearing overbought territory.
  • Anticipated earnings report is scheduled approximately 78 days from now.

Expert Opinions on D-Wave Quantum

Over the last month, various analysts have provided insights on D-Wave Quantum stock, with an average target price set at $42.50.

Turn $1000 into $1270 in just 20 days?

A seasoned options trader claims to have a technique that demonstrates optimal buy and sell points, achieving an average of 27% profit every 20 days.

With several analysts adjusting their ratings, here’s a brief summary:

  • Evercore ISI analysts have downgraded their assessment to Outperform with a target price of $44.
  • Wedbush analysts have also moderated their rating to Outperform, establishing a target price of $35.
  • At Jefferies, the rating has been revised downward to Buy, now predicting a price target of $45.
  • Mizuho analysts have lowered their rating to Outperform with a new price objective of $46.

Options trading can present greater risks along with the potential rewards. In these environments, vigilant traders protect themselves through continuous education about market strategies, various indicators, and the ongoing watch of market response. Staying updated on D-Wave Quantum's options activity is vital for any serious investor.

Frequently Asked Questions

What is D-Wave Quantum's recent stock activity?

Recently, D-Wave Quantum experienced a stock price decrease of around 3.47%, which is notable in the current market.

How are experts viewing D-Wave Quantum's stock?

Experts currently have a positive outlook, with an average target price of $42.50 based on recent ratings.

What significant trades were reported for D-Wave Quantum?

Key trades include both bullish and bearish sentiments with various call and put options, showcasing diverse investor strategies.

What industries does D-Wave Quantum serve?

D-Wave operates in many sectors including logistics, AI, materials science, drug discovery, and financial modeling.

How does options trading affect D-Wave Quantum?

Options trading can influence investor sentiment and stock price volatility, reflecting market expectations for D-Wave Quantum.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 2

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 0

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Securiti Earns Noteworthy AWS Security Competency in AI

Updated Category News Views 375

Securiti Achieves AWS Security Competency Status in AI Security Securiti, the pioneer of the Data+AI Command Center, proudly announces its recent achievement of Amazon Web Services (AWS) Security Competency status in the innovative AI Security category. This new milestone highlights Securiti as one of the select inaugural partners recognized by AWS for its exceptional...

Continue Reading
Exciting Family Medicine Forum in Winnipeg This Fall

Updated Category News Views 204

Join the Family Medicine Forum in Winnipeg Mark your calendars, as the Family Medicine Forum is heading to Winnipeg this November for an enriching experience that promises to bring together family physicians from across the nation. This premier event is not only a chance to learn but to celebrate the vital work family doctors do every day. The Essence of Family Medicine...

Continue Reading
Man Group PLC Reveals Interest in Dowlais Group Securities

Updated Category News Views 106

Understanding the Disclosure by Man Group PLC In the realm of financial markets, disclosures play a crucial role in maintaining transparency and informing stakeholders about significant market movements. Recently, Man Group PLC made headlines by revealing its position regarding Dowlais Group PLC's relevant securities. This disclosure is essential as it reflects the...

Continue Reading
Experity Welcomes Bobby Ghoshal as New COO and President

Updated Category News Views 371

Experity Welcomes Bobby Ghoshal as President and COO Experity, a leader in on-demand healthcare solutions, has appointed Bobby Ghoshal as its new President and Chief Operating Officer. In this important role, Mr. Ghoshal will spearhead daily operations, steering the strategic direction for the company. His appointment is pivotal in enhancing Experity's mission to serve...

Continue Reading
LifeMD's Upcoming Engagements at Major Investor Conferences

Updated Category News Views 96

LifeMD's Upcoming Engagements at Major Investor Conferences LifeMD, Inc. (Nasdaq: LFMD), a trailblazer in virtual primary care, has recently announced its participation in several prominent investor conferences this September. As a company recognized for its innovative approach in telemedicine, LifeMD’s management is eager to showcase their vision and accomplishments to...

Continue Reading